All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

Permanence Bio

Developing therapeutics to stop mutations to prevent cancer

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$35.0M·Jan 2026
Capacity Bio

Mitochondria-focused biotechnology company developing novel mitophagy modulators

Los Angeles, United States1–10Life Sciences
Series A·$35.0M·Mar 2023
Vial

Next-generation pharma company using computationally designed therapeutics and automated clinical...

San Francisco, United States51–200Life Sciences, Biotech
Series B·$34.0M·Nov 2022
Bevel

AI health companion app that unifies wearable, lab, and habit data to deliver personalized insigh...

Palo Alto, United States11–50Life Sciences, Beauty
Series B·$33.3M·Sep 2015
Apheris

Life sciences data networks for AI

Berlin, Germany11–50Artificial Intelligence, Life Sciences
Series A·$33.1M·Jan 2025
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Life Sciences
Series C·$33.0M·Jan 2015
Shyft

Indian health and wellness platform offering online nutrition consultations, coaching, and plant-...

Gurugram, India11–50Life Sciences, Healthcare
Series B·$31.0M·Sep 2022
Fate TherapeuticsIPO

Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for aut...

La Jolla, United States51–200Biotech, Life Sciences
Series B·$30.0M·Nov 2009
Lottie

Lottie connects families with elderly care homes through a user-friendly platform.

London, United Kingdom51–200Life Sciences, Healthcare
Series A·$29.6M·Oct 2023
Great Bay Bio 大湾生物

By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long t...

San Francisco Bay Area, China51–200Artificial Intelligence, Biotech
Series B·$28.8M·Dec 2024
Envisagenics

AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for ...

Long Island City, United States11–50Artificial Intelligence, Biotech
Series B·$27.4M·Jun 2024
Story HealthAcquired

AI-enabled care platform that extends specialty care into patients' homes for health systems and ...

Cupertino, United States11–50Life Sciences, Artificial Intelligence
Series A·$26.6M·Feb 2022
Eyebot

Builds 90-second vision-test kiosks that deliver doctor-verified eyeglass prescriptions for retai...

Boston, United States11–50Life Sciences, Artificial Intelligence
Series A·$26.0M·Aug 2025
BiotheusAcquired

Biotheus is a clinical development stage company treating cancer and autoimmune diseases through ...

Life Sciences
Series B·$26.0M·Mar 2021
Converge Bio

Generative AI platform for accelerated drug discovery and molecule design serving pharma and biot...

Tel Aviv, Israel11–50Artificial Intelligence, Biotech
Series A·$25.0M·Jan 2025
FibroBiologics

Biopharmaceutical company developing fibroblast cell-based therapies for autoimmune and degenerat...

Houston, United States11–50Biotech, Healthcare
Corporate Round·$25.0M·Dec 2024
Better Health

Provides insurance-covered home delivery of medical supplies plus peer support, coaching, and tel...

San Francisco, United States11–50Life Sciences, Digital Health
Series A·$24.0M
Core InformaticsAcquired

Scientific data management for pharma

Branford, United StatesLaboratory Software, Life Sciences
Series B·$22.5M·Jan 2016
ArrePath

ArrePath is a biotech company discovering and developing new and differentiated classes of anti-i...

Princeton, United States11–50Life Sciences
Series A·$21.3M·Jun 2025
Primus Senior Living

Operator of senior living communities in India offering wellness-focused residential living and e...

Bengaluru, India51–200Life Sciences, Healthcare
Seed·$20.0M·Oct 2024
Osana

Osana builds AI-powered digital infrastructure for healthcare operations in Latin America, enabli...

San Francisco, United States51–200Life Sciences, Artificial Intelligence
Series A·$20.0M·Aug 2021
Birches Health

Provides insurance-covered virtual counseling specializing in gambling and behavioral addictions ...

New York, United States1–10Life Sciences, Digital Health
Series A·$19.8M·Aug 2025
Evvy

At-home vaginal microbiome testing and care platform offering metagenomic sequencing, clinician-r...

San Francisco, United States11–50Life Sciences, Biotech
Series A·$19.0M·Sep 2023
AmgenIPO

Develops and manufactures biologic medicines treating serious illnesses and improving patient out...

Thousand Oaks, United States10001+Biotech, Healthcare
Venture Unknown·$19.0M·Apr 1980
Laurus Bio

India-based integrated biomanufacturing organization with deep expertise in precision fermentatio...

Hyderabad, India51–200Biotech, Life Sciences
Series A·$18.9M·Dec 2024